InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 17, 2025 20:48 ET | Source: InnoCare Pharma BEIJING, Dec. 17,…
Xinhua Silk Road: Conference held in E. China biz hub to highlight burgeoning regional M&As
BEIJING, Dec. 15, 2025 /PRNewswire/ -- When gaining speed in building a…
CGTN: How does China set tone for economic work in 2026?
BEIJING, Dec. 12, 2025 /PRNewswire/ -- With Chinese leaders gathered in Beijing…
JASCAYD (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
The approval marks the first new treatment option for people living with…
Xinhua Silk Road: Conference to bolster role of talents held in south China FTP
BEIJING, Dec. 10, 2025 /PRNewswire/ -- A conference leveraging Hainan's large reservoir of…
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration OpportunitiesBEIJING, Dec. 7, 2025 /PRNewswire/ -- …
CGTN: What makes cooperation between China and France a two-way success
BEIJING, Dec. 5, 2025 /PRNewswire/ -- With French President Emmanuel Macron currently…
Xinhua Silk Road: Discover China with foreign friends
BEIJING, Nov. 30, 2025 /PRNewswire/ -- Do you want to visit China?…
Xinhua Silk Road: Conference highlights ancient port site of Maritime Silk Road held in Wenzhou, E. China
BEIJING, Nov. 29, 2025 /PRNewswire/ -- In east China coastal city of Wenzhou, a…
Empowering AI Acceleration: openEuler Unveils First SuperPoD-Ready OS and Welcomes AMD, Inspur Cloud, and Digital China
BEIJING, Nov. 29, 2025 /PRNewswire/ -- The OpenAtom openEuler community ("openEuler") successfully concluded…
